Romain Neugebauer to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Romain Neugebauer has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.312
-
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
Score: 0.205
-
Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP). J Gen Intern Med. 2015 Nov; 30(11):1645-50.
Score: 0.107